Compare J.B.Chemicals with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs IPCA LABS - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS IPCA LABS J.B.CHEMICALS/
IPCA LABS
 
P/E (TTM) x 22.6 32.0 70.6% View Chart
P/BV x 4.2 6.7 62.9% View Chart
Dividend Yield % 0.3 0.2 154.3%  

Financials

 J.B.CHEMICALS   IPCA LABS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
IPCA LABS
Mar-19
J.B.CHEMICALS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3631,042 34.8%   
Low Rs255590 43.2%   
Sales per share (Unadj.) Rs169.1298.6 56.6%  
Earnings per share (Unadj.) Rs16.635.0 47.4%  
Cash flow per share (Unadj.) Rs23.449.4 47.4%  
Dividends per share (Unadj.) Rs2.003.00 66.7%  
Dividend yield (eoy) %0.60.4 176.0%  
Book value per share (Unadj.) Rs172.5247.1 69.8%  
Shares outstanding (eoy) m83.57126.35 66.1%   
Bonus/Rights/Conversions BBESOS-  
Price / Sales ratio x1.82.7 66.9%   
Avg P/E ratio x18.623.3 79.9%  
P/CF ratio (eoy) x13.216.5 80.0%  
Price / Book Value ratio x1.83.3 54.3%  
Dividend payout %12.08.6 140.6%   
Avg Mkt Cap Rs m25,827103,108 25.0%   
No. of employees `0003.813.4 28.1%   
Total wages/salary Rs m2,5117,874 31.9%   
Avg. sales/employee Rs Th3,747.42,807.0 133.5%   
Avg. wages/employee Rs Th665.7585.8 113.6%   
Avg. net profit/employee Rs Th367.8329.0 111.8%   
INCOME DATA
Net Sales Rs m14,13537,732 37.5%  
Other income Rs m366577 63.4%   
Total revenues Rs m14,50138,309 37.9%   
Gross profit Rs m2,1786,901 31.6%  
Depreciation Rs m5701,824 31.2%   
Interest Rs m35189 18.5%   
Profit before tax Rs m1,9405,465 35.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5521,042 53.0%   
Profit after tax Rs m1,3874,422 31.4%  
Gross profit margin %15.418.3 84.3%  
Effective tax rate %28.519.1 149.3%   
Net profit margin %9.811.7 83.7%  
BALANCE SHEET DATA
Current assets Rs m10,47023,778 44.0%   
Current liabilities Rs m2,74910,975 25.0%   
Net working cap to sales %54.633.9 161.0%  
Current ratio x3.82.2 175.8%  
Inventory Days Days55104 53.2%  
Debtors Days Days7866 117.8%  
Net fixed assets Rs m5,81120,368 28.5%   
Share capital Rs m167253 66.1%   
"Free" reserves Rs m14,24830,971 46.0%   
Net worth Rs m14,41631,224 46.2%   
Long term debt Rs m01,409 0.0%   
Total assets Rs m17,64945,507 38.8%  
Interest coverage x56.630.0 188.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 96.6%   
Return on assets %8.110.1 79.5%  
Return on equity %9.614.2 67.9%  
Return on capital %13.717.3 79.1%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m6,16417,308 35.6%   
Fx outflow Rs m1,3346,266 21.3%   
Net fx Rs m4,82911,042 43.7%   
CASH FLOW
From Operations Rs m1,2314,923 25.0%  
From Investments Rs m-208-1,563 13.3%  
From Financial Activity Rs m-595-1,832 32.5%  
Net Cashflow Rs m4271,528 28.0%  

Share Holding

Indian Promoters % 55.4 45.9 120.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 11.4 29.7%  
FIIs % 3.9 25.3 15.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.4 212.6%  
Shareholders   30,437 36,892 82.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFESCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 2, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - ALKEM LABORATORIES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS